title: Hsp90 (heat shock protein 90) inhibitor occupancy is a direct determinant of client protein degradation and tumor growth arrest in vivo.
authors.affiliation: Infinity Pharmaceuticals, Cambridge, Massachusetts 02139, USA. bonnie.tillotson@infi.com
authors.forename: Bonnie
authors.initials: B
authors.lastname: Tillotson
authors.forename: Kelly
authors.initials: K
authors.lastname: Slocum
authors.forename: John
authors.initials: J
authors.lastname: Coco
authors.forename: Nigel
authors.initials: N
authors.lastname: Whitebread
authors.forename: Brian
authors.initials: B
authors.lastname: Thomas
authors.forename: Kip A
authors.initials: KA
authors.lastname: West
authors.forename: John
authors.initials: J
authors.lastname: MacDougall
authors.forename: Jie
authors.initials: J
authors.lastname: Ge
authors.forename: Janid A
authors.initials: JA
authors.lastname: Ali
authors.forename: Vito J
authors.initials: VJ
authors.lastname: Palombella
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Normant
authors.forename: Julian
authors.initials: J
authors.lastname: Adams
authors.forename: Christian C
authors.initials: CC
authors.lastname: Fritz